CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Health

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $30,000.00 income · posted Oct 17, 2025

Lobbying activity 1

Health Issues

Metachromatic Leukodystrophy included on Recommended Uniform Screening Panel (RUSP) Metachromatic Leukodystrophy treatment

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.